![]() | Up a level |
Journal Article
Doebele, Robert C., Dziadziuszko, Rafal, Drilon, Alexander, Shaw, Alice T., Wolf, Juergen, Farago, Anna F., Dennis, Lucas, Riehl, Todd, Simmons, Brian, Wu, Charlie, Chang, Ching-Wei, Choeurng, Voleak and Wilson, Timothy R. (2020). Genomic Landscape of Entrectinib Resistance from Circulating Tumor DNA (CTDNA) Analysis in STARTRK-2. Oncol. Res. Treat., 43. S. 217 - 218. BASEL: KARGER. ISSN 2296-5262
Drilon, Alexander, Lin, Jessica J., Filleron, Thomas, Ni, Ai ORCID: 0000-0003-3002-3556, Milia, Julie, Bergagnini, Isabella, Hatzoglou, Vaios, Velcheti, Vamsidhar, Offin, Michael, Li, Bob, Carbone, David P., Besse, Benjamin
ORCID: 0000-0001-5090-8189, Mok, Tony, Awad, Mark M., Wolf, Jurgen, Owen, Dwight
ORCID: 0000-0002-6598-4886, Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Kris, Mark G., Mazieres, Julien, Gainor, Justin F. and Gautschi, Oliver
(2018).
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
J. Thorac. Oncol., 13 (10).
S. 1595 - 1602.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Gautschi, Oliver, Milia, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David P., Owen, Dwight ORCID: 0000-0002-6598-4886, Camidge, Ross, Narayanan, Vignhesh, Doebele, Robert C.
ORCID: 0000-0001-6728-6857, Besse, Benjamin
ORCID: 0000-0001-5090-8189, Remon-Masip, Jordi, Janne, Pasi A., Awad, Mark M., Peled, Nir, Byoung, Chul-Cho, Karp, Daniel D., Van Den Heuvel, Michael, Wakelee, Heather A., Neal, Joel W., Mok, Tony S. K., Yang, James C. H., Ou, Sai-Hong Ignatius, Pall, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, JonathanW., Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Frueh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay
ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha I., Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian
ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander
(2017).
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
J. Clin. Oncol., 35 (13).
S. 1403 - 1414.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Gautschi, Oliver, Milia-Baron, Julie, Filleron, Thomas, Wolf, Juergen, Carbone, David, Owen, Dwight, Camidge, D. Ross, Narayanan, Vighesh, Doebele, Robert, Besse, Benjamin ORCID: 0000-0001-5090-8189, Remon, Jordi, Janne, Pasi, Awad, Mark, Peled, Nir, Byoung, Chul-Cho, Karp, Daniel, Van den Heuve, Michael, Wakelee, Heather, Nea, Joel, Mok, Tony, Yang, James Chih-Hsin, Ou, Sai-Hong, Pa, Georg, Froesch, Patrizia, Zalcman, Gerard, Gandara, David R., Riess, Jonathan, Velcheti, Vamsidhar, Zeidler, Kristin, Diebold, Joachim, Fruh, Martin, Michels, Sebastian, Monnet, Isabelle, Popat, Sanjay
ORCID: 0000-0003-2087-4963, Rosell, Rafael, Karachaliou, Niki, Rothschild, Sacha
ORCID: 0000-0003-1304-9340, Shih, Jin-Yuan, Warth, Arne, Muley, Thomas, Cabillic, Florian
ORCID: 0000-0001-7204-5652, Mazieres, Julien and Drilon, Alexander
(2017).
Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers.
J. Thorac. Oncol., 12 (1).
S. S435 - 2.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Paz-Ares, Luis, Dziadziuszko, Rafal, Drilon, Alexander, John, Thomas, Krebs, Matthew, Demetri, George, Shaw, Alice T., Siena, Salvatore, Wolf, Juergen, Farago, Anna F., Simmons, Brian, Pitcher, Bethany, Huang, Xinhui and Doebele, Robert (2020). Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases. Oncol. Res. Treat., 43. S. 235 - 236. BASEL: KARGER. ISSN 2296-5262
Solomon, Benjamin J., Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jurgen, Elamin, Yasir, Davis, Hannah M., Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K., Loong, Herbert H., Novello, Silvia, Arriola, Edurne, Perol, Maurice, Goto, Koichi and Santini, Fernando C. . Phase III study of selpercatinib vs chemotherapy plus /- pembrolizumab in untreated RET positive non-small-cell lung cancer. Future Oncol.. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301
Subbiah, Vivek, Wolf, Jurgen, Konda, Bhavana, Kang, Hyunseok, Spira, Alexander, Weiss, Jared, Takeda, Masayuki, Ohe, Yuichiro, Khan, Saad, Ohashi, Kadoaki, Soldatenkova, Victoria, Szymczak, Sylwia, Sullivan, Loretta, Wright, Jennifer and Drilon, Alexander (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol., 23 (10). S. 1261 - 1274. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488